Edward T. Mathers - Jun 23, 2022 Form 4 Insider Report for Trevi Therapeutics, Inc. (TRVI)

Role: Director
Signature: /s/ Louis Citron, attorney-in-fact
Stock symbol: TRVI
Transactions as of: Jun 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/23/2022, 05:04 PM
Previous filing: Jun 14, 2022
Next filing: Jul 15, 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TRVI	Nonstatutory Stock Option (right to buy)	Award	$0	+20K		$0.00	20K	Jun 23, 2022	Common Stock	20K	$2.27	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 23, 2022. This option is scheduled to fully vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the next annual meeting of stockholders of the Issuer held following the date of grant, subject to the recipient's continued service as a director, employee or consultant of the Issuer.